Lipocine Inc. financial data

Symbol
LPCN on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 Arapeen Drive, Suite 202, Salt Lake City, US
State of incorporation
DE
Fiscal year end
December 31
Former names
MARATHON BAR CORP (to 7/9/2013)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.22K % -19.8%
Debt-to-equity 8.89 % +29%
Return On Equity -19.2 % +65.1%
Return On Assets -17.6 % +65.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.35M shares +0.6%
Common Stock, Shares, Outstanding 5.35M shares +0.6%
Entity Public Float 25.6M USD -63%
Common Stock, Value, Issued 8.86K USD +0.03%
Weighted Average Number of Shares Outstanding, Basic 5.35M shares +1.06%
Weighted Average Number of Shares Outstanding, Diluted 5.35M shares +1.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 89.6K USD
Revenue from Contract with Customer, Excluding Assessed Tax 55K USD
Research and Development Expense 7.95M USD -21.8%
General and Administrative Expense 5.26M USD +12.9%
Operating Income (Loss) -5.29M USD +70.4%
Nonoperating Income (Expense) 1.24M USD +4.91%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.05M USD +75.1%
Income Tax Expense (Benefit) 481 USD
Net Income (Loss) Attributable to Parent -4.06M USD +75.1%
Earnings Per Share, Basic -0.74 USD/shares +80.2%
Earnings Per Share, Diluted -0.77 USD/shares +79.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.74M USD -8.1%
Assets, Current 20.5M USD -16.7%
Property, Plant and Equipment, Net 171K USD +48.5%
Other Assets, Noncurrent 23.8K USD 0%
Assets 20.7M USD -16.4%
Accounts Payable, Current 285K USD -74.1%
Accrued Liabilities, Current 1.29M USD +13.3%
Liabilities, Current 1.58M USD -29.5%
Liabilities 1.58M USD -30.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9.94K USD
Retained Earnings (Accumulated Deficit) -202M USD -2.05%
Stockholders' Equity Attributable to Parent 19.1M USD -15%
Liabilities and Equity 20.7M USD -16.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.41M USD
Net Cash Provided by (Used in) Financing Activities -6.02M USD -859%
Net Cash Provided by (Used in) Investing Activities -4.09M USD -174%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.35M shares +0.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.69M USD -204%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14.9K USD -70.5%
Deferred Tax Assets, Valuation Allowance 47.8M USD +4.14%
Deferred Tax Assets, Gross 47.8M USD +4.13%
Payments to Acquire Property, Plant, and Equipment 4K USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.03M USD +75.2%
Lessee, Operating Lease, Liability, to be Paid 153K USD +3%
Property, Plant and Equipment, Gross 1.3M USD +1.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 61.3K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 61.3K USD +3%
Preferred Stock, Shares Issued 88.5K shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 221M USD +0.3%
Preferred Stock, Shares Outstanding 88.5K shares
Interest Expense 104K USD -64.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%